1. 2160 GIV as a novel marker of recurrence risk in MMR proficient stage II colon cancer. (September 2015) Authors: Gibbs, P; Tie, J.; Ghosh, P; Muranyi, A.; Brunhoeber, P; Singh, S.; LaFluer, B.; Xu, C.; Leith, K.; Tran, B.; Desai, J.; Martinez, R.; Goel, A.; Waring, P; Hu, S.; Teichgraeber, V.; Rohr, U.P; Ridder, R.; Shanmugam, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗